The Efficacy and Safety of Intracranial Stent (Tonbridge) in Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis

NCT05757505 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-01-02

No results posted yet for this study

Summary

The purpose of this study is to verify the efficacy and safety of the Intracranial Stent (Tonbridge) in endovascular treatment of symptomatic intracranial atherosclerotic stenosis.

Conditions

  • Intracranial Atherosclerosis

Interventions

DEVICE

Intracranial Stent (Tonbridge)

Endovascular treatment with Intracranial Stent (Tonbridge).

DEVICE

Wingspan Stent System (Stryker Neurovascular)

Endovascular treatment with Wingspan Stent System (Stryker Neurovascular).

Sponsors & Collaborators

  • Ton-Bridge Medical Tech. Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Jianmin Liu · Changhai Hospital

  • Shouchun Wang · The First Hospital of Jilin University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-11
Primary Completion
2026-01-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05757505 on ClinicalTrials.gov